secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001193125-24-275534
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks reports annual meeting results and amends director compensation policy
--------------------------------------------------------------------------------

- Elected four directors with 82-99% votes for; KPMG ratified as auditor with 96.86% votes for.
- Advisory vote on named executive officer compensation approved with 93.33% votes for.
- Board increased R&D committee retainer from $6,000 to $7,500 effective Jan 1, 2025.
- Initial option grant for new directors reduced from 74k to 62k shares; annual grant from 37k to 31k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524275534/0001193125-24-275534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524275534/d903989d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-275534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer